Evidence is accumulating that directly responsible for the rate of progress
ion of glomerular disease are specific positive (cyclins and cyclin-depende
nt kinases) and negative (cyclin-kinase inhibitors) cell cycle regulatory p
roteins. The challenge for nephrologists is to determine which ones are exp
ressed in renal disease and their precise role in glomerular cell prolifera
tion, hypertrophy and differentiation. Ultimately the goal is to find ever
more appropriate therapeutic strategies to arrest or prevent progressive re
nal disease.